The 52-Week Low Club
Some very large companies made today’s 52-week low list. Constellation Brands (STZ) The large distiller said 2008 earnings would be poor, and poor enough to send the stock down 15% today to $20.04. The 52-week high: $29.17. IndyMac Bancorp (NDE)…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Some very large companies made today’s 52-week low list.
Constellation Brands (STZ) The large distiller said 2008 earnings would be poor, and poor enough to send the stock down 15% today to $20.04. The 52-week high: $29.17.
IndyMac Bancorp (NDE) Not a sub-prime lender but the slow housing market is hitting this home lending operation. Down to over 6% on profit warning to $32.16 and off more after hours to $31.60. The 52-week high: $50.50.
McClatchy Newspapers (MNI) This newspaper company seems to want to stay on the list. Recently reported that January advertising sales are down. Off another 1% today to $36.99. Perhaps the CEO will make the 24/7 list of chiefs who have to go. The 52-week high: $55.66.
AVANIR Pharma. (AVNR) Problems with FDA on approval of Zenvia™ as a treatment for involuntary emotional expression disorder. Another very ugly day with stock down over 17% to $1.54. The 52-week high: $18.14.
Horizon Offshore (HOFF) The company provides construction for offshore oil and gas sites. Company reported that revenue fell in Q4 06. Stock was pounded down over 15% to $14.03. The 52-week high: $24.
Transmeta (TMTA) Yesterday’s drop after poor earnings was not enough. Stock in microprocessing intellectual property business dropped another 6% to $.67. Got back a little after hours. The 52-week high: $2.37.
Amgen (AMGN) A big surprise to see one of the great growth stocks of the last decade on the list. In 1996, AMGN was a $13 stock. Hit $77 over the last 12 months, but today reached a 52-week low of $61.70. The biotech’s big anemia drug, Aranesp, is facing safety issues.
Douglas A. McIntyre can be reached at [email protected]. He does not own securities in companies that he writes about.
Contact [email protected] for any questions or corrections.
Douglas A. McIntyre is the co-founder, chief executive officer and editor in chief of 24/7 Wall St. and 24/7 Tempo. He has held these jobs since 2006.
McIntyre has written thousands of articles for 24/7 Wall St. He is an expert on corporate finance, the automotive industry, media companies and international finance. He has edited articles on national demographics, sports, personal income and travel.
His work has been quoted or mentioned in The New York Times, The Wall Street Journal, Los Angeles Times, The Washington Post, NBC News, Time, The New Yorker, HuffPost USA Today, Business Insider, Yahoo, AOL, MarketWatch, The Atlantic, Bloomberg, New York Post, Chicago Tribune, Forbes, The Guardian and many other major publications. McIntyre has been a guest on CNBC, the BBC and television and radio stations across the country.
A magna cum laude graduate of Harvard College, McIntyre also was president of The Harvard Advocate. Founded in 1866, the Advocate is the oldest college publication in the United States.
TheStreet.com, Comps.com and Edgar Online are some of the public companies for which McIntyre served on the board of directors. He was a Vicinity Corporation board member when the company was sold to Microsoft in 2002. He served on the audit committees of some of these companies.
McIntyre has been the CEO of FutureSource, a provider of trading terminals and news to commodities and futures traders. He was president of Switchboard, the online phone directory company. He served as chairman and CEO of On2 Technologies, the video compression company that provided video compression software for Adobe’s Flash. Google bought On2 in 2009.
